MNBTD
PACB icon

Moody National Bank Trust Division’s Pacific Biosciences PACB Stock Holding History

Moody National Bank Trust Division’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-228
Closed -$2K – 792
2019
Q1 		$2K Buy
+228
New +$1.65K ﹤0.01% 1161

Other funds holding PACB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Moody National Bank Trust Division's PACB Position: Q2 2019 in Review

Moody National Bank Trust Division sold out of Pacific Biosciences (PACB) in Q2 2019, closing a stake of 228 shares — an estimated $2K sold.

Moody National Bank Trust Division first reported a position in PACB in Q1 2019 and held it in 1 quarter. The position peaked at $2K in Q1 2019. 150 funds tracked by Wall St. Rank hold PACB as of Q2 2019.

  • Moody National Bank Trust Division reported no remaining Pacific Biosciences position as of Q2 2019 after selling out during the quarter.
  • Moody National Bank Trust Division sold 228 Pacific Biosciences shares in Q2 2019, an estimated $2K.
  • Moody National Bank Trust Division first reported a position in Pacific Biosciences in Q1 2019 and held it in 1 quarter.
  • Moody National Bank Trust Division's Pacific Biosciences position peaked at $2K in Q1 2019.
  • 150 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2019.

Based on Moody National Bank Trust Division's 13F filing for Q2 2019, filed 22 Jul 2019.